Skip to main content

The Design of Health Care Financing Schemes in Different Countries

  • Chapter
  • First Online:
  • 1698 Accesses

Part of the book series: Developments in Health Economics and Public Policy ((HEPP,volume 10))

Abstract

In this chapter, the conceptual analysis developed in the previous chapter is applied to the following countries: Australia, Belgium, France, Germany, Ireland, Israel, the Netherlands, Switzerland and the United States. In particular, we discuss the conformity of the actual design of these OECD countries’ health care financing schemes with the economic arguments for mandatory cross-subsidies and for mandatory coverage. We observe that several countries (e.g. Australia, Belgium, France and Israel) opted for the introduction of universal mandatory coverage for a comprehensive and uniform package of services. As discussed in Chap. 2 this measure is not per se necessary and proportionate to achieve an affordable access to (the coverage of) health care services for vulnerable groups. Alternatively, governments could rely either on the two-option scheme or the single-option scheme with voluntary income-related deductibles. Although the latter scheme is likely to be preferable from an economic perspective, it is not implemented in any of the considered countries. Only the Netherlands and Switzerland come close to this scheme given that they have implemented a single-option scheme with traditional deductibles (fixed amounts) for curative health care services. However, the fixed deductible levels may be too high for low-income people and too low for high-income individuals. In addition, long-term care services are covered by a universal single-option scheme with mandatory income-related copayments in the Netherlands (AWBZ). As far as the two-option scheme is concerned, it is implemented in Germany and Ireland. Nevertheless, the high-option scheme for low-income people seems to be too broad in Germany and too small in Ireland.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    These studies are consistent with the literature (Newhouse 1993b). It has to be acknowledged that the overall price-elasticity, which equals −0.14 for the six types of care in van Vliet (2004), is in the middle of the range reported by the RAND study. This indicates that according to the RAND experiment individuals are on average more sensitive to price-variations for the different types of care than the Dutch privately insured.

  2. 2.

    However, the RAND study used high copayments rates that seem unthinkable in the context of most countries considered here.

  3. 3.

    For long-term care (e.g. nursing home care), the Netherlands implemented a universal single-option scheme (i.e. AWBZ) with mandatory income-related copayments.

References

  • Buchner, F., & Wasem, J. (2003). Needs for further improvement: risk adjustment in the German health insurance system. Health Policy, 65(1), 21–35.

    Article  PubMed  Google Scholar 

  • Butler, J. R. G. (2007). Adverse selection in Australian private health insurance. ACERH Policy Forum.

    Google Scholar 

  • Connelly, L. B., & Brown, H. S., III. (2006). Lifetime subsidies in Australian private health insurance markets with community rating. The Geneva Papers, 31, 705–719.

    Article  Google Scholar 

  • Desmond, K. A., Rice, T., & Fox, P. D. (2006). Does greater Medicare HMO enrollment cause adverse selection into Medigap? Health Economics, Policy and Law, 1(1), 3–21.

    Article  Google Scholar 

  • Ergas, H., & Paolucci, F. (2010). Providing and financing aged care in Australia (mimeo).

    Google Scholar 

  • Ettner, S. L. (1997). Adverse selection and the purchase of Medigap Insurance by the elderly. Journal of Health Economics, 16(5), 543–562.

    Article  PubMed  CAS  Google Scholar 

  • Murray, C. J. L., Lauer, J. A., Hutubessy, R. C. W., Niessen, L., Tomijima, N., Rodgers, A., et al. (2003). Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis onreduction of cardiovascular-disease risk. Lancet, 361, 717–725.

    Article  PubMed  Google Scholar 

  • Paolucci, F., Butler, J. R. G., & van de Ven, W. P. M. M. (2008). Subsidising private health insurance in Australia: Why, how and how to proceed? ACERH Working Paper Series 2, October 2008.

    Google Scholar 

  • Private Health Insurance Administration Council (PHIAC). (2007). Operations of the Private Health Insurers: Annual Report 2006–07. Canberra: PHIAC.

    Google Scholar 

  • Private Health Insurance Administration Council (PHIAC). (2009). Operations of the Private Health Insurers: Annual Report 2008–09. Canberra: PHIAC.

    Google Scholar 

  • Sandier, S., & Ulmann, P. (2001). Voluntary health insurance in France: a study for the European Commission. Paris: ARgeSES/CNAM.

    Google Scholar 

  • Schokkaert, E., & Van de Voorde, C. (2003). Belgium: Risk adjustment and financial responsibility in a centralised system. Health Policy, 65(1), 5–19.

    Article  PubMed  Google Scholar 

  • Shmueli, A., Chernivkovsky, D., & Zmora, I. (2003). Risk adjustment and risk sharing: The Israeli experience. Health Policy, 65(1), 37–48.

    Article  PubMed  Google Scholar 

  • Steinbrook, R. M. D. (2006). Health care reform in Massachusetts – A work in progress. New England Journal of Medicine, 354, 2095–2098.

    Article  PubMed  CAS  Google Scholar 

  • Newhouse, J. P. (1993b). Free for all? Lessons from the RAND health insurance experiment. Cambridge, Massachusetts: Harvard University Press.

    Google Scholar 

  • Van de Ven, W. P. M. M., Beck, K., Van de Voorde, C., Wasem, J., & Zmora, I. (2007). Risk adjustment and risk selection in Europe: 6 years later. Health Policy, 83(2–3), 162–179.

    PubMed  Google Scholar 

  • Van de Ven, W. P. M. M., & Schut, F. T. (2008). Universal mandatory health insurance in the Netherlands: A model for the United States? Health Affairs, 27(3), 771–781.

    Article  PubMed  Google Scholar 

  • Van de Ven, W. P. M. M., & Schut, F. T. (2009). Managed competition in the Netherlands: still work-in-progress. Health Economics, 18(3), 253–255.

    Article  PubMed  Google Scholar 

  • Van de Ven, W. P. M. M., van Vliet, R. C. J. A., Schut, F. T., & van Barneveld, E. M. (2000). Access to coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies? Journal of Health Economics, 19(3), 311–339.

    Article  PubMed  Google Scholar 

  • Van Kleef, R. C., Beck, K., van de Ven, W. P. M. M., & van Vliet, R. C. J. A. (2007). Does risk equalization reduce the viability of voluntary deductibles? International Journal of Health Care Finance and Economics, 7, 43–58.

    Article  PubMed  Google Scholar 

  • Van Kleef, R. C., van de Ven, W. P. M. M., & van Vliet, R. C. J. A. (2006). A voluntary deductible in social health insurance with risk equalization: Community-rated or risk-rated premium rebate? Journal of Risk and Insurance, 73(3), 359–550.

    Article  Google Scholar 

  • Van Vliet, R. C. J. A. (2004). Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data. International Journal of Health Care Finance and Economics, 4(4), 283–305.

    Article  PubMed  Google Scholar 

  • Wolfe, J. R., & Goddeeris, J. H. (1991). Adverse selection, moral hazard, and wealth effects in the Medigap insurance market. Journal of Health Economics, 10(4), 433–459.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Paolucci PhD .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Paolucci, F. (2011). The Design of Health Care Financing Schemes in Different Countries. In: Health Care Financing and Insurance. Developments in Health Economics and Public Policy, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-10794-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-10794-8_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-10793-1

  • Online ISBN: 978-3-642-10794-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics